30.03.2022 • News

Global Sciences Buys Pure BioPlastics

Global Sciences, a Canadian multinational consumer goods company that also specializes in cannabidiol (CBD) products, has executed a binding letter of intent to buy Pure BioPlastics from Pure Vision Technology. The move follows six months of due diligence and discovery between the companies.

Following the transaction’s closure, which is expected on or before Apr. 15, Global Sciences will create a Bio-based Technologies division, headed by Pure BioPlastics founder Ed Lehrburger.

Based in Fort Lupton, Colorado, Pure BioPlastics was initially established to scale up PureVision’s patented continuous countercurrent reactor (CCR) technology that converts non-food biomass such as hemp, corn stalks, switchgrass and wheat straw into pulp, lignin and sugars.

The technology has been proven at pilot-scale and Global Sciences plans to fund the scale-up of processing capability from 0.5 t/d to 8 t/d within 16-24 months. Ultimately, the firm intends to develop a 60 t/d CCR-based biorefinery, capable of future expansion.

Because the bio-based plastic created by the technology is 100% sourced from plant material, the composition of the principal product can be manipulated to control the timeline of the plastic degradation, Global Sciences said, adding that this characteristic would support a wide variety of “designer” biodegradable products, including straws, lids and plastic components for cars and aircraft.

Author: Elaine Burridge, Freelance Journalist

 

(c) Vardan Papikyan
(c) Vardan Papikyan

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.